Sitemap > Clinical Trials > Technology
Displaying 1 - 50 of 2410 results
- A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.
- Bevacizumab and Abraxane as Second-Line Therapy in Triple Negative Metastatic Breast Cancer
- Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
- PEPCAD III Substudy: Stem Cell Mobilization
- A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
- Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children.
- Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above
- TYSABRI® Global Observational Program in Safety
- A Phase I/IIa Multicenter Dose-Escalation Study of Subcutaneous Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Patients With CD4 T-Lymphocyte Counts Between 101-400 Cells/mm(3) and Plasma HIV RNA Less Than 1000 Copies/ml After at Least 12 Months of HAART
- Bortezomib (Velcade) and Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
- Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
- A Phase II Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer
- M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
- Cetuximab in Treating Patients At High Risk of Developing Stomach Cancer
- Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
- Dendritic Cell Vaccine for High Risk Ovarian ca
- Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
- A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
- Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100
- Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
- Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas in First Line of Treatment for the Metastatic Disease
- A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
- A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)
- A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
- Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients
- Study of NGR-hTNF as Single Agent in Patients Affected by Metastatic Small Cell Lung Carcinoma
- A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma
- A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528
- A Study to Evaluate the Safety and Tolerability of Multiple IV Doses of an Antibody, in Patients With Systemic Lupus Erythematosus
- Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
- Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
- Phase II Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globlulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)
- Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation
- Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
- A Study of Apomab in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer
- A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
- Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
- Efficacy, Safety, Reactogenicity & Immunogenicity of the Human Rotavirus Vaccine (HRV) 444563 in Japanese Infants
- GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
- Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis
- A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
- Gleevec & Docetaxel Study in Head and Neck Squamous Cell Cancer Patients
- A Phase II Study of EC17 (Folate-Hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma
- Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma